Hussman Strategic Advisors’s Organogenesis Holdings ORGO Stock Holding History

Hussman Strategic Advisors’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-31,000	Closed	-$236K	–	354
2022 Q1	$236K	Hold	31,000	–	–	0.05%	286
2021 Q4	$286K	Hold	31,000	–	–	0.06%	283
2021 Q3	$441K	Hold	31,000	–	–	0.1%	252
2021 Q2	$515K	Buy	+31,000	New	+$578K	0.11%	259
2020 Q4	–	Sell	-100,000	Closed	-$384K	–	300
2020 Q3	$384K	Sell	100,000 -100,000	-50%	-$395K	0.1%	227
2020 Q2	$768K	Hold	200,000	–	–	0.2%	183
2020 Q1	$646K	Hold	200,000	–	–	0.17%	199
2019 Q4	$962K	Buy	+200,000	New	+$1.27M	0.31%	123

Other funds holding ORGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Hussman Strategic Advisors's ORGO Position: Q2 2022 in Review

Hussman Strategic Advisors sold out of Organogenesis Holdings (ORGO) in Q2 2022, closing a stake of 31,000 shares — an estimated $236K sold.

Hussman Strategic Advisors first reported a position in ORGO in Q4 2019 and held it in 8 quarters. The position peaked at $962K in Q4 2019. 146 funds tracked by Wall St. Rank hold ORGO as of Q2 2022.

Hussman Strategic Advisors reported no remaining Organogenesis Holdings position as of Q2 2022 after selling out during the quarter.
Hussman Strategic Advisors sold 31,000 Organogenesis Holdings shares in Q2 2022, an estimated $236K.
Hussman Strategic Advisors first reported a position in Organogenesis Holdings in Q4 2019 and held it in 8 quarters.
Hussman Strategic Advisors's Organogenesis Holdings position peaked at $962K in Q4 2019.
146 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2022.

Based on Hussman Strategic Advisors's 13F filing for Q2 2022, filed 12 Sep 2022.